5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.06▼ | 1.07▼ | 1.07▼ | 1.10▼ | 1.10▼ |
MA10 | 1.08▼ | 1.10▼ | 1.11▼ | 1.10▼ | 1.26▼ |
MA20 | 1.11▼ | 1.14▼ | 1.15▼ | 1.08▼ | 1.46▼ |
MA50 | 1.15▼ | 1.11▼ | 1.08▼ | 1.27▼ | 1.20▼ |
MA100 | 1.13▼ | 1.06▼ | 1.10▼ | 1.49▼ | 1.19▼ |
MA200 | 1.09▼ | 1.18▼ | 1.24▼ | 1.25▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.006▼ | -0.016▼ | -0.018▼ | 0.012▲ | -0.077▼ |
RSI | 30.229▼ | 32.636▼ | 36.739▼ | 37.733▼ | 38.871▼ |
STOCH | 21.810 | 8.083▼ | 13.778▼ | 54.815 | 16.448▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -81.481▼ | -89.612▼ |
CCI | -147.786▼ | -185.871▼ | -175.836▼ | -60.281 | -105.288▼ |
Wednesday, April 30, 2025 01:05 PM
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that Dirk ...
|
Tuesday, April 29, 2025 09:29 PM
2-Year U.S. Treasury Note Continuous Contract $103.926-0.035-0.03% 5-Year U.S. Treasury Note Continuous Contract $108.875-0.055-0.05% 10-Year U.S. Treasury Note Continuous Contract $111.844-0.063 ...
|
Friday, April 25, 2025 08:21 AM
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 1.04 | 1.04 | 1.02 | 1.02 | 36,808 |
01/05/25 | 1.12 | 1.15 | 1.03 | 1.08 | 148,642 |
30/04/25 | 1.13 | 1.18 | 1.07 | 1.10 | 78,536 |
29/04/25 | 1.165 | 1.165 | 1.14 | 1.145 | 27,169 |
28/04/25 | 1.24 | 1.24 | 1.13 | 1.133 | 544,928 |
25/04/25 | 1.13 | 1.24 | 1.1275 | 1.23 | 45,730 |
24/04/25 | 1.06 | 1.13 | 1.01 | 1.125 | 97,379 |
23/04/25 | 1.05 | 1.06 | 0.97 | 1.06 | 70,222 |
22/04/25 | 1.07 | 1.10 | 1.03 | 1.05 | 175,309 |
21/04/25 | 1.04 | 1.055 | 0.9888 | 1.05 | 91,695 |
|
|
||||
|
|
||||
|
|